Day: August 9, 2022

Brands revenue increased 20% year-over-year Brands subscription revenue increased 27% year-over-year Adjusted EBITDA exceeds guidance Repurchased $25 million of common stock RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) — ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions that enable brands and retailers to increase global sales, today reported financial results for the quarter and six months ended June 30, 2022. Second Quarter 2022 HighlightsGAAPTotal revenue of $42.8 million was above the midpoint of the guidance range Subscription revenue increased 13% year-over-year, or 16% excluding the unfavorable impact from year-over-year changes in foreign currency exchange rates Brands revenue increased 20% year-over-year, or 25% excluding the unfavorable impact from year-over-year...

Net Sales grew 38.6% in the second quarter 2022 Company re-affirms fiscal year 2022 guidance SANTA BARBARA, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”), today announced financial results for the second quarter and six months ended June 30, 2022. For the second quarter of 2022 compared to the second quarter 2021:Net sales increased 38.6% to $210.9 million;Net sales increased 41.3% in the United States and 35.2% internationally By channel:Professional grew 32.7% to $105.5 million; Specialty Retail increased 68.5% to $64.2 million; Direct-To-Consumer rose 19.3% to $41.2 millions;Net income increased 77.7% and adjusted net income increased 35.5%; Diluted EPS were $0.13 for the second quarter 2022, as compared to $0.08 for the second quarter 2021; Adjusted Diluted...

Second Quarter 2022 Marketplace GOV of $815 million and Revenues of $148 million CHICAGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”, “we” or the “Company”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today provided financial results for the second quarter ended June 30, 2022. “We are pleased to deliver another exceptionally strong quarter and one in which we delivered record-setting Q2 Marketplace GOV which was driven by a record-setting number of Marketplace Orders across all quarters,” said Stan Chia, Vivid Seats CEO. “Our performance is a testament to the power of our business model, the success of our strategy, and the long-term secular growth that we expect...

Patient Enrollment into BEACON Phase 1/2 Trial of BEAM-101 On-track for Second Half of 2022 BEAM-201 IND Submitted to FDA; Currently on Clinical Hold BEAM-102 IND Submission and BEAM-301 IND-enabling Studies On-track for Second Half of 2022 John Lo, Ph.D., Appointed as Chief Commercial Officer Ended Second Quarter 2022 with $1.2 Billion in Cash, Cash Equivalents and Marketable Securities to Support Advancement of Broad Precision Genetic Medicines Portfolio CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today provided pipeline and business updates and reported financial results for the second quarter ended June 30, 2022. “2022 is a critical year for Beam’s transition to becoming a multi-program clinical-stage...

Over $300 Million in Capital Added to Balance Sheet, Supporting an Operating Runway into Second Half of 2025 Patient Dosing Underway with Lead Candidate, VERVE-101, for Treatment of Heterozygous Familial Hypercholesterolemia; Regulatory Clearances in the United Kingdom and United States Anticipated in Second Half of 2022 Preclinical Data Supporting Nomination of ANGPTL3 Development Candidate, VERVE-201, to be Presented at the European Society of Cardiology 2022 Congress; Initiation of IND-enabling Studies Expected in the Second Half of 2022 Research Collaboration with Vertex and Amendment to Beam License Agreement Expanded Pipeline Adding Two Additional Targets Lonnel Coats and Alexander G. “Bo” Cumbo Join Board of Directors, Supporting Company’s Evolution and Growth CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics,...

Second Quarter Highlights and Recent DevelopmentsSecond quarter revenue of $30.7 million  Added new top 10 utility customer and new strategic EPC customer Awarded first project in Thailand, continuing international expansion Added $141 million to executed contracts and awarded orders since May 9 Announced EPC partner for distributed generation (DG) business, AUI Partners Closed acquisition of HX TrackerAUSTIN, Texas, Aug. 09, 2022 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software and engineering services, today announced financial results for the second quarter ended June 30, 2022. “Second quarter results were generally in-line with our expectations,” said Sean Hunkler, FTC Solar President and Chief Executive Officer, “and reflect what has been a challenging solar-module...